APA (7th ed.) Citation

AB, I., G, A., EJ, W., G, R., S, P., L, C., . . . K, S. (2018). Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling. Cancer cell, 34(6), 922. https://doi.org/10.1016/j.ccell.2018.11.005

Chicago Style (17th ed.) Citation

AB, Iniguez, et al. "Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling." Cancer Cell 34, no. 6 (2018): 922. https://doi.org/10.1016/j.ccell.2018.11.005.

MLA (9th ed.) Citation

AB, Iniguez, et al. "Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling." Cancer Cell, vol. 34, no. 6, 2018, p. 922, https://doi.org/10.1016/j.ccell.2018.11.005.